Your to Good Health




$0.00 Update cart

Price excludes delivery, which is applied at checkout. Orders will be processed in CAD


More omega-3, fewer respiratory events

Omega-3 polyunsaturated fatty acids (DHA+EPA+DPA) possess properties that may be protective in chronic obstructive pulmonary disease (COPD). Using the Multi-Ethnic Study of Atherosclerosis (MESA), researchers hypothesized that higher plasma levels of n-3 PUFAs would be associated with a slower progression of percent emphysema on CT, a slower decline in lung function, and a lower risk of chronic lower respiratory disease (CLRD) events.

Harvard scholars have found that Omega-3 may increase brain volumes in infants

Scholars at Harvard Medical School and Boston Children’s Hospital have suggested that maternal dietary intake of Omega-3 fatty acids correlates positively with regional brain volumes in 1-month-old term infants.Omega-3 fatty acids remained significantly correlated with infant brain volumes after subsetting to the 54 infants who were exclusively breastfed, but retinol and vitamin B12 did not.

DPA (abundant in seal oil) is an important player in the Omega-3 family

Recent results showed that n-3 DPA is implied in the improvement of cardiovascular and metabolic disease risk markers, especially plasma lipid parameters, platelet aggregation, and cellular plasticity. Moreover, n-3 DPA is the most abundant n-3 LCPUFA in the brain after DHA and it could be specifically beneficial for elderly neuroprotection, and early-life development.